0001213900-23-072561.txt : 20230830
0001213900-23-072561.hdr.sgml : 20230830
20230830215231
ACCESSION NUMBER: 0001213900-23-072561
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230817
FILED AS OF DATE: 20230830
DATE AS OF CHANGE: 20230830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hubbell Randolph W
CENTRAL INDEX KEY: 0001984207
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40228
FILM NUMBER: 231226838
MAIL ADDRESS:
STREET 1: C/O CARMELL THERAPEUTICS CORPORATION
STREET 2: 2403 SIDNEY STREET, SUITE 300
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Carmell Corp
CENTRAL INDEX KEY: 0001842939
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1177 AVENUE OF THE AMERICAS
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 646-494-3296
MAIL ADDRESS:
STREET 1: 1177 AVENUE OF THE AMERICAS
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
FORMER COMPANY:
FORMER CONFORMED NAME: Carmell Therapeutics Corp
DATE OF NAME CHANGE: 20230727
FORMER COMPANY:
FORMER CONFORMED NAME: ALPHA HEALTHCARE ACQUISITION CORP III
DATE OF NAME CHANGE: 20210127
4
1
ownership.xml
X0508
4
2023-08-17
0
0001842939
Carmell Corp
CTCX
0001984207
Hubbell Randolph W
C/O CARMELL CORPORATION
2403 SIDNEY STREET, SUITE 300
PITTSBURGH
PA
15203
1
1
0
0
President and CEO
0
Common Stock
2023-08-17
4
P
0
450
3.72
A
450
D
Common Stock
2023-08-18
4
P
0
1200
3.735
A
1650
D
Common Stock
2023-08-21
4
P
0
300
3.6667
A
1950
D
Common Stock
2023-08-22
4
P
0
100
3.51
A
2050
D
Common Stock
2023-08-23
4
P
0
200
3.605
A
2250
D
Common Stock
2023-08-24
4
P
0
200
3.57
A
2450
D
Common Stock
2023-08-25
4
P
0
200
3.50
A
2650
D
Common Stock
2023-08-28
4
P
0
100
3.49
A
2750
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.54 to $3.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.65 to $3.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.63 to $3.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.58 to $3.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 4.
/s/ Randolph W. Hubbell
2023-08-30